Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein uS12 is a universally conserved component of the small ribosomal subunit (30S in bacteria and 40S in eukaryotes) and plays a pivotal role in maintaining the fidelity of protein synthesis. Located at the decoding center of the ribosome, uS12 monitors the accuracy of codon-anticodon interactions, ensuring that the correct aminoacyl-tRNA is selected during translation. In bacteria, uS12 (encoded by the rpsL gene) is a well-characterized target for the aminoglycoside antibiotic streptomycin, which binds to the decoding site and induces misreading of the genetic code. Mutations in uS12 are a common mechanism of high-level streptomycin resistance, often leading to 'hyper-accurate' ribosomes that exhibit reduced translation rates. In humans, the uS12 homolog is known as RPS23; mutations in this protein have been linked to rare ribosomopathies, such as brachycephaly, trichomegaly, and developmental delay (BTDD). Additionally, uS12 has been implicated in extra-ribosomal functions, including cell competition and stress response signaling, and its expression levels are altered in certain cancers.
Streptomycin binds to the decoding center of the small ribosomal subunit, interacting with 16S rRNA and the uS12 protein to stabilize the closed conformation of the ribosome and promote translational misreading. Dityromycin binds directly to uS12, inhibiting translocation by trapping elongation factor G (EF-G) on the ribosome.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein uS12 (uS12).